Kymera Therapeutics Inc (NAS:KYMR)
$ 114.89 +0.78 (+0.68%) Market Cap: 9.45 Bil Enterprise Value: 8.88 Bil PE Ratio: 0 PB Ratio: 6.13 GF Score: 46/100

Kymera Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 02:10 PM GMT
Release Date Price: $86.35 (-4.16%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KYMR.OQ - Kymera Therapeutics Inc
Kymera Therapeutics Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 02:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome back to the forty-sixth annual TD Cowan Healthcare Conference. I'm Mark Franm from the Biotech team here at TD Cowan. We're really happy to, have with us, Nello and Jared from Chimera, CEO and CMO, to talk about a variety of programs that we'll probably spend a lot of time on. Stat 6, but we will definitely get to some other programs as well. Maybe to start off with Nello, you want to kind of give a high level kind of status update of the company maybe and what you view as kind of key value creating milestones for, shareholders over the next 1,224 months.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot